Dietary Prevention of Cancer
饮食预防癌症
基本信息
- 批准号:7405370
- 负责人:
- 金额:$ 27.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAKT inhibitionAdenocarcinomaAffectAngiogenic FactorApoptosisApoptosis PromoterApoptoticAzoxymethaneBAX geneBax proteinBiochemicalCause of DeathCell ProliferationCell SurvivalColonColon CarcinomaColonic AdenomaCultured CellsCurcuminDevelopmentDietDinoprostoneDiseaseDrug Delivery SystemsDrug resistanceEGF geneEffectivenessEnd PointEpidermal Growth FactorEpidermal Growth Factor ReceptorFood SupplementsGene TargetingGenus ColaGoalsGrowthGrowth FactorHumanHypoxiaIn VitroIncidenceIntestinesLigandsMAPK14 geneMAPK8 geneMalignant NeoplasmsMatrix MetalloproteinasesMediatingMethodsMolecularMusNeoplasm MetastasisNude MicePathway interactionsPharmaceutical PreparationsPhosphorylationPhosphotransferasesPopulationPreventiveProcessProstaglandinsProstaglandins EProtein KinaseProtein Tyrosine KinaseProtein p53Proto-Oncogene Proteins c-aktRattusReceptor Protein-Tyrosine KinasesRegulationResistanceRiskRoleSignal PathwaySignal TransductionSolid NeoplasmSourceSpecificitySpicesStagingTP53 geneTherapeuticTumericTumor AngiogenesisTumor BiologyTumor Suppressor ProteinsUnited StatesVascular Endothelial Growth Factorsadenomaangiogenesiscancer cellcancer preventionchemotherapeutic agentchemotherapyclinical phenotypecolon cancer cell linecyclooxygenase 2dietary constituentdietary supplementsgenetic manipulationin vivoinsightirinotecanmicrobial alkaline proteinase inhibitormigrationmutantneoplastic cellneovascularizationnoveloncoprotein p21polyphenolpreventreceptorresponsetranscription factortumortumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Colon Cancer is a leading cause of death in the United States. Accordingly, methods of preventing this disease or discovery of agents that increase effectiveness of existing chemotherapeutic agents would be very beneficial. Our studies and those of others have indicated that dietary curcumin, an active ingredient in the spice turmeric, potently inhibits intestinal tumorigenesis. We have now characterized the mechanisms by which curcumin modulates this function. Proliferation, angiogenesis and tumor invasiveness constitute the major pathways that are necessary for the growth and metastatic potential of cancer. Our preliminary studies show that curcumin inhibits cell proliferation, and tumor angiogenesis and invasiveness, while it enhances spontaneous and chemotherapy-induced apoptosis of tumor cells. The goals of the current project are to determine the mechanistic effects of curcumin on each of theses processes. Specifically, we will determine the effects of curcumin on growth factor-mediated activation of cellular signaling pathways. We will also determine the role of curcumin in signaling mediated by epidermal growth factor and prostaglandins, two molecules that are active in cancer progression. In addition, we will determine the effect of curcumin on the expression and regulation of tumor suppressor protein p53, an important regulator of cell survival. We will examine the effect of curcumin on expression of p53 target genes such as p21 WAF1, BAX. Moreover, we will examine the role of curcumin in the expression of VEGF and related angiogenesis factors as well as matrix metalloproteinases as regulators of tumor invasiveness. We will compare the results obtained in cell culture studies with that observed in mice with defined genetic manipulations. Together these studies should provide insight into the cancer process and how curcumin suppresses the risk and proliferation of colon cancer, and of no less importance, why curcumin is of great value as a food supplement.
描述(由申请人提供):结肠癌是美国的主要死因。因此,预防这种疾病的方法或发现增加现有化疗剂有效性的药剂将是非常有益的。我们和其他人的研究表明,饮食姜黄素,香料姜黄中的活性成分,有效地抑制肠道肿瘤的发生。我们现在已经描述了姜黄素调节这一功能的机制。增殖、血管生成和肿瘤侵袭性构成了癌症生长和转移潜力所必需的主要途径。我们的初步研究表明,姜黄素抑制细胞增殖,肿瘤血管生成和侵袭,同时它增强自发和化疗诱导的肿瘤细胞凋亡。目前项目的目标是确定姜黄素对这些过程中的每一个的机械作用。具体来说,我们将确定姜黄素对生长因子介导的细胞信号通路激活的影响。我们还将确定姜黄素在表皮生长因子和胡萝卜素介导的信号传导中的作用,这两种分子在癌症进展中具有活性。此外,我们将确定姜黄素对肿瘤抑制蛋白p53的表达和调节的影响,p53是细胞存活的重要调节因子。我们将研究姜黄素对p53靶基因如p21 WAF 1,BAX表达的影响。此外,我们将研究姜黄素在VEGF和相关血管生成因子以及基质金属蛋白酶作为肿瘤侵袭调节因子的表达中的作用。我们将比较在细胞培养研究中获得的结果与在小鼠中观察到的确定的遗传操作。总之,这些研究应该提供深入了解癌症过程以及姜黄素如何抑制结肠癌的风险和增殖,以及同样重要的是,为什么姜黄素作为食品补充剂具有巨大价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shrikant Anant其他文献
Shrikant Anant的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shrikant Anant', 18)}}的其他基金
6th Annual Midwest Tumor Microenvironment Meeting
第六届中西部肿瘤微环境年会
- 批准号:
10002411 - 财政年份:2020
- 资助金额:
$ 27.43万 - 项目类别:
Bitter Melon Component and Colon Cancer Prevention
苦瓜成分与预防结肠癌
- 批准号:
8796002 - 财政年份:2014
- 资助金额:
$ 27.43万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
9198492 - 财政年份:2014
- 资助金额:
$ 27.43万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
8627820 - 财政年份:2014
- 资助金额:
$ 27.43万 - 项目类别:
Bitter Melon Component and Colon Cancer Prevention
苦瓜成分与预防结肠癌
- 批准号:
9321795 - 财政年份:2014
- 资助金额:
$ 27.43万 - 项目类别:
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
用于结肠癌治疗的新型双Notch/PXR靶向
- 批准号:
9144740 - 财政年份:2014
- 资助金额:
$ 27.43万 - 项目类别:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
肠上皮细胞中的 RNA 结合蛋白 CUGBP2
- 批准号:
7583130 - 财政年份:2009
- 资助金额:
$ 27.43万 - 项目类别:
RNA Binding Protein CUGBP2 in Intestinal Epithelium
肠上皮细胞中的 RNA 结合蛋白 CUGBP2
- 批准号:
7924796 - 财政年份:2009
- 资助金额:
$ 27.43万 - 项目类别:
相似海外基金
Elucidating resistance to AKT inhibition in metastatic breast cancer
阐明转移性乳腺癌对 AKT 抑制的耐药性
- 批准号:
2440937 - 财政年份:2020
- 资助金额:
$ 27.43万 - 项目类别:
Studentship
The Risk of Novel AKT Inhibition on Lethal Neuroendocrine Prostate Cancer Development
新型 AKT 抑制对致死性神经内分泌前列腺癌发展的风险
- 批准号:
350042 - 财政年份:2015
- 资助金额:
$ 27.43万 - 项目类别:
Studentship Programs
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition
癌细胞对 PI3K/AKT 抑制的适应性反应的机制研究
- 批准号:
9272854 - 财政年份:2015
- 资助金额:
$ 27.43万 - 项目类别:
Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer
通过 CDK 和 AKT 抑制作用靶向胰腺癌中的 RAS 信号传导
- 批准号:
8581465 - 财政年份:2013
- 资助金额:
$ 27.43万 - 项目类别:
Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer
通过 CDK 和 AKT 抑制作用靶向胰腺癌中的 RAS 信号传导
- 批准号:
8692694 - 财政年份:2013
- 资助金额:
$ 27.43万 - 项目类别: